Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Vistagen Therapeutics (VTGN)

Vistagen Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VTGN
DateTimeSourceHeadlineSymbolCompany
06/12/202421:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTGNVistagen Therapeutics Inc
14/11/202421:53Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VTGNVistagen Therapeutics Inc
14/11/202421:19Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VTGNVistagen Therapeutics Inc
14/11/202413:30Business WireVistagen to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:VTGNVistagen Therapeutics Inc
07/11/202421:34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTGNVistagen Therapeutics Inc
07/11/202421:20Business WireVistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate UpdateNASDAQ:VTGNVistagen Therapeutics Inc
05/11/202413:30Business WireVistagen to Present at the 2024 Neuroscience Education Institute CongressNASDAQ:VTGNVistagen Therapeutics Inc
01/11/202412:30Business WireVistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024NASDAQ:VTGNVistagen Therapeutics Inc
09/10/202412:30Business WireVistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health DayNASDAQ:VTGNVistagen Therapeutics Inc
23/09/202412:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTGNVistagen Therapeutics Inc
23/09/202412:30Business WireVistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety DisorderNASDAQ:VTGNVistagen Therapeutics Inc
10/09/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTGNVistagen Therapeutics Inc
10/09/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTGNVistagen Therapeutics Inc
10/09/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTGNVistagen Therapeutics Inc
10/09/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTGNVistagen Therapeutics Inc
28/08/202420:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTGNVistagen Therapeutics Inc
13/08/202420:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTGNVistagen Therapeutics Inc
13/08/202420:49Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTGNVistagen Therapeutics Inc
13/08/202420:21Business WireVistagen Reports Fiscal Year 2025 First Quarter Financial Results and Corporate UpdateNASDAQ:VTGNVistagen Therapeutics Inc
06/08/202412:30Business WireVistagen to Report Fiscal Year 2025 First Quarter Results and Host Corporate Update Conference Call on August 13, 2024NASDAQ:VTGNVistagen Therapeutics Inc
12/07/202420:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTGNVistagen Therapeutics Inc
10/07/202420:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTGNVistagen Therapeutics Inc
09/07/202412:30Business WireVistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of MigraineNASDAQ:VTGNVistagen Therapeutics Inc
27/06/202412:30Business WireVistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive YearNASDAQ:VTGNVistagen Therapeutics Inc
11/06/202420:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTGNVistagen Therapeutics Inc
11/06/202420:27Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VTGNVistagen Therapeutics Inc
11/06/202420:20Business WireVistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate UpdateNASDAQ:VTGNVistagen Therapeutics Inc
11/06/202411:07IH Market NewsU.S. Index Futures Fall Ahead of Federal Reserve Policy Meeting, Crude Oil Prices DeclineNASDAQ:VTGNVistagen Therapeutics Inc
07/06/202412:30Business WireVistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024NASDAQ:VTGNVistagen Therapeutics Inc
31/05/202420:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTGNVistagen Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VTGN

Your Recent History